Webster Andrew
Department of Sociology, SATSU, University of York, York, YO10 5DD, UK.
Regen Med. 2017 Oct;12(7):853-864. doi: 10.2217/rme-2017-0028. Epub 2017 Nov 2.
This paper asks how regenerative medicine can be examined through the 'responsible research and innovation' (RRI) approach which has been developed over the past decade. It describes the drivers to the development of RRI, and then argues for the need to understand innovation itself through drawing on social science analysis rooted in science and technology studies. The paper then identifies a number of highly specific challenges faced by the regenerative medicine field and the implications these have for value creation. It offers a number of examples of how a combined RRI/science and technology studies perspective can identify priority areas for policy and concludes by arguing for a 'responsible acceleration', more likely to foster readiness at a time when much of the policy domain is pushing for ever-rapid access to cell therapies.
本文探讨了如何通过过去十年间发展起来的“责任研究与创新”（RRI）方法来审视再生医学。文中描述了RRI发展的驱动因素，进而主张有必要借助源于科学技术研究的社会科学分析来理解创新本身。接着，本文指出了再生医学领域面临的一些非常具体的挑战以及这些挑战对价值创造的影响。文中给出了若干示例，说明RRI与科学技术研究相结合的视角如何能够确定政策的优先领域，并在结尾主张进行“负责任的加速”，在当前许多政策领域都在推动尽快获得细胞疗法的情况下，这种加速更有可能促进准备就绪。
